Differential subcellular distribution of rat prostatic steroid 5α-reductase isozyme activities

European Journal of Endocrinology

Volumn 134, Issue 3, 1996, Pages 386-392

  Span, Paul N ^a   Sweep, C G J ^a   Benraad, Theo J ^a   Smals, Anthony G H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID 5ALPHA REDUCTASE;

ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; RAT; STEROIDOGENESIS;

EID: 0029923097     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340386     Document Type: Article

References (42)

1. Russell DW, Wilson JD. Steroid 5α-reductase: two genes/two enzymes. Annu Rev Biochem 1994;63:25-61
2. Schneider JJ, Hortsmann PM, Effects of incubating desoxycorticosterone with various rat tissues. J Biol Chem 1951;191:327-38
3. Schneider JJ. Conversion of desoxycorticosterone to four allopregnane metabolites by rat liver in vitro. J Biol Chem 1952;199:235-44
4. Bruchovsky N, Wilson JD. The conversion of testosterone to 5α-androstan-17β-ol-3-one by rat prostate in vivo and in vitro. J Biol Chem 1968;243:2012-21
5. Wilson JD, Gloyna RE. The intranuclear metabolism of testosterone in the accessory organs of reproduction. Recent Prog Horm Res 1970;26:309-36
6. Frederiksen DW, Wilson JD. Partial characterization of the nuclear reduced nicotinamide adenine dinucleotide phosphate: Δ4-3-ketosteroid 5α-oxidoreductase of rat prostate. J Biol Chem 1971;246:2584-93
7. Shimazaki J, Horaguchi T, Ohki Y, Shida K. Properties of testosterone 5α-reductase of purified nuclear fraction from ventral prostates of rats. Endocrinol Jpn 1971;18:179-87
8. Anderson KM, Liao S. Selective retention of dihydrotestosterone by prostatic nuclei. Nature 1968;219:277-9
9. Fang S, Anderson KM, Liao S. Receptor proteins for androgens. On the role of specific proteins in selective retention of 17β-hydroxy-5α-androstan-3-one by ventral prostate in vivo and in vitro. J Biol Chem 1969;244:6584-95
10. Mainwaring WIP. A soluble androgen receptor in the cytoplasm of rat prostate. J Endocrinol 1969;45:531-41
11. Farkash Y, Soreq H, Orly J. Biosynthesis of catalytically active rat testosterone 5α-reductase in microinjected Xenopus oocytes: evidence for tissue specific differences in translatable mRNA. Proc Natl Acad Sci USA 1989;85:5824-8
12. Andersson S, Bishop RW, Russell DW. Expression cloning and regulation of steroid 5α-reductase, an enzyme essential for male sexual differentiation. J Biol Chem 1989;264:16249-55
13. Andersson S, Russell DW. Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc Natl Acad Sci USA 1990;87:3640-4
14. Andersson S, Berman DM, Jenkins EP, Russell DW. Deletion of steroid 5α-reductase II gene in male pseudohermaphroditism. Nature 1991;354:159-61
15. Jenkins EP, Andersson S, Imperato-McGinley J, Wilson JD, Russell DW. Genetic and pharmacological evidence for more than one human steroid 5α-reductase. J Clin Invest 1992;89:293-300
16. Normington K, Russell DW. Tissue distribution and kinetic characteristics of rat steroid 5α-reductase isozymes. J Biol Chem 1992;267:19548-54
17. Moore RJ, Wilson JD. Extraction of the reduced nicotinamide adenine dinucleotide phosphate: Δ4-3-ketosteroid-5α-oxidoreductase of rat prostate with digitonin and potassium chloride. Biochemistry 1972;29:450-6
18. Verhoeven G, Lamberigts G, De Moor P. Nucleus-associated steroid 5α-reductase activity and androgen responsiveness. A study in various organs and brain regions of rats. J Steroid Biochem 1974;5:93-100
19. Moore RJ, Wilson JD. Localization of the reduced nicotinamide adenine dinucleotide phosphate Δ4-3-ketosteroid-5α-oxidoreductase in the nuclear membrane of the rat ventral prostate. J Biol Chem 1974;247:958-67
20. Enderle-Schmitt U, Volck-Badouin E, Schmitt J, Aumuller G. Functional characteristics of nuclear 5α-reductase from rat ventral prostate. J Steroid Buochem 1986;25:209-17
21. Houston B, Chisholm GD, Habib FK. Evidence that human prostatic 5α-reductase is located exclusively in the nucleus. FEBS Lett 1985;185:231-5
22. Enderle-Schmitt U, Neuhaus C, Aumuller G. Solubilization of nuclear steroid 5α-reductase from rat ventral prostate. Biochim Biophys Acta 1989;987:21-8
23. Hiipakka RA, Wang, M, Bloss T, Ito K, Iiao S. Expression of 5α-reductase in bacteria as a trp E fusion protein and its use in the production of antibodies for immunocytochemical localization of 5α-reductase. J Steroid Biochem Mol Biol 1993;45:539-48
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin reagent. J Biol Chem 1951;193: 265-75
25. Span RN, Smals AGH, Sweep CGJ, Benraad TJ. Rat steroid 5α-reductase kinetic characteristics, extreme pH-dependency of the type II isozyme in prostate and epididymis homogenates. J Steroid Biochem Mol Biol 1995;54:185-92
26. Span PN, Benraad TJ, Sweep CGJ, Smals AGH. Kinetic analysis of steroid 5α-reductase activity at neutral pH in benign prostatic hyperplastic tissue: evidence for type I isozyme activity in the human prostate. J Steroid Biochem Mol Biol 1995. In press
27. Segel IH. Enzyme kinetics. New York: Wiley 1975
28. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW. Tissue distribution and ontogeny of steroid 5α-reductase expression. J Clin Invest 1993;92:903-10
29. Faller B, Farley D, Hick HP. Finasteride: a slow-binding 5α-reductase inhibitor. Biochemistry 1993;32:5705-10
30. Thigpen AE, Cala KM, Russell DW. Characterization of Chinese Hamster Ovary cell lines expressing human steroid 5α-reductase isozymes. J Biol Chem 1993;268:17404-12
31. Savory JGA, May D, Reich T, La Casse EC, Lakins J, Tenniswood M, et al. 5α-reductase type I is localized to the outer nuclear membrane. Mol Cell Endocrinol 1995;110:137-47
32. Liao SS, Kokontis J, Sai T, Hiipakka RA. Androgen receptors: structures, mutations, antibodies and cellular dynamics. Steroid Biochem 1989;34:41-51
33. Husmann DA, Wilson CM, McPhaul MJ, Tilley WD, Wilson JD. Antipeptide antibodies to two distinct regions of the androgen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate. Endocrinology 1990;126:2359-68
34. 1 oxidoreductase of rat ventral prostate. Biochemistry 1975;14:810-7
35. Berman DM, Russell DW. Cell-type specific expression of rat steroid 5α-reductase isozymes. Proc Natl Acad Sci USA 1993;90:9359-63
36. Rittmaster RS, Manning AP, Wright AS, Thomas LN, Whitefield S, Norman RW, et al. Evidence for atrophy and apoptosis in the ventral prostates of rats given the 5α-reductase inhibitor finasteride. Endocrinology 1995;136:741-8
37. Cunha GR, Chung LW, Shannon JM, Reese BA. Stromal-epithelial interactions in sex differentiation. Biol Reprod 1980; 22:19-42
38. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, et al. The endocrinology and development biology of the prostate. Endocr Rev 1987;8:338-62
39. Walsh PC, Wilson JD. The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest 1976;57:1093-7
40. Imperato-McGinley J, Gautier T, Zirinsky K, Hom T, Palomo O, Stein E, et al. Prostate visualization studies in males homozygous and heterozygous for 5α-reductase deficiency. J Clin Endocrinol Metab 1992;75:1022-6
41. Gormley GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, et al. The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 1992; 327:1185-91
42. Labrie F. Intracrinology. Mol Cell Endocrinol 1991;78:C113-8